# Curosurf

NDC: 10122-510
Generic name: poractant alfa
Labeler / Manufacturer: Chiesi USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: SUSPENSION
Routes: ENDOTRACHEAL
Marketing started: 19991118

FDA application: BLA020744

## Active ingredients

- PORACTANT ALFA: 80 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10122-510"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10122-510
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=99bef307-00bd-4379-9f45-ede1380e74d4